OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Medical Screening is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada	111
Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer	42
Impact of COVID-19-related care disruptions on cervical cancer screening in the United States	32
Google search volume trends for cancer screening terms during the COVID-19 pandemic	20
Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis	17
Incidence of inborn errors of metabolism detected by tandem mass spectrometry in China: A census of over seven million newborns between 2016 and 2017	17
COVID-19 disruption to cervical cancer screening in England	17
Assessment of breast positioning criteria in mammographic screening: Agreement between artificial intelligence software and radiographers	16
Cervical screening attendance and cervical cancer risk among women who have sex with women	15
The randomized trial of mammography screening that was not—A cautionary tale	13
Systematic reviews as a “lens of evidence”: Determinants of participation in breast cancer screening	13
The impact of socioeconomic deprivation on the uptake of colorectal cancer screening in London	13
Folic acid and neural tube defects: Discovery, debate and the need for policy change	12
Early detection of breast cancer rectifies inequality of breast cancer outcomes	11
Interval colorectal cancers after negative faecal immunochemical test in a 13-year screening programme	11
Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs	11
Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England	10
Determination of methylmalonic acid, 2-methylcitric acid, and total homocysteine in dried blood spots by liquid chromatography–tandem mass spectrometry: A reliable follow-up method for propionylcarnit	10
Modeling costs and benefits of the organized colorectal cancer screening programme and its potential future improvements in Hungary	10
Retrospective analysis of the effect on interval cancer rate of adding an artificial intelligence algorithm to the reading process for two-dimensional full-field digital mammography	10
Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study	9
A novel mobile phone application for infant stool color recognition: An easy and effective tool to identify acholic stools in newborns	9
All-cause mortality as the primary endpoint for the GRAIL/National Health Service England multi-cancer screening trial	8
Decentralising atrial fibrillation screening to overcome socio-demographic inequalities in uptake in STROKESTOP II	8
Factors associated with attendance and attendance patterns in a population-based mammographic screening program	8

Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia	8
Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records	8
Cost-effectiveness analysis of lung cancer screening with low-dose computed tomography in an Iranian high-risk population	8
Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost–utility analysis	8
Factors affecting patient adherence to lung cancer screening: A multisite analysis	7
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study	7
The UK National Screening Committee’s position on child–parent screening for familial hypercholesterolaemia	7
Systematic review and meta-analysis of colon capsule endoscopy accuracy for colorectal cancer screening. An alternative during the Covid-19 pandemic?	6
Retrospective comparison between single reading plus an artificial intelligence algorithm and two-view digital tomosynthesis with double reading in breast screening	6
Impact of the COVID-19 pandemic on colorectal cancer screening in New York City	6
Prognostic selection and long-term survival analysis to assess overdiagnosis risk in lung cancer screening randomized trials	6
Benefits of digital breast tomosynthesis: A lesion-level analysis	5
Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme	5
Screening participants’ attitudes to the introduction of artificial intelligence in breast screening	5
Afterthoughts on colonoscopy. Was it that bad?	5
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing	5
Impact of an organised population screening programme for colorectal cancer: Measurement after first and second rounds	5
Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data	4
Women screened for breast cancer are dying from lung cancer: An opportunity to improve lung cancer screening in a mammography population	4
The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis	4
The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening	4
Major failings of trial procedures and quality of screening fatally compromise the results of the Canadian National Breast Screening Studies	4
The feasibility and necessity of cancer screening events in the community during the COVID-19 pandemic in Taiwan	4
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020	4
Did the use of open invitations in place of timed appointment invitations reduce the uptake of breast screening in the London region during the COVID-19 recovery?	4
Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study	4
Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies	4
Beneficial effect of repeated participation in breast cancer screening upon survival	3
Test accuracy of artificial intelligence-based grading of fundus images in diabetic retinopathy screening: A systematic review	3
Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test	3
The ties that bind: Cancer history, communication, and screening intention associations among diverse families	3
Incidence of interval breast cancer among women aged 45–49 in an organised mammography screening setting	3
Implementation of a centralized HPV-based cervical cancer screening programme in Tuscany: First round results and comparison with the foregoing Pap-based screening programme	3
Disparities in the use of regular pap smears among migrant and non-migrant women in Austria: A population-based survey of 7633 women	3
Quality measures of a multicentre universal newborn hearing screening program in Malaysia	3
Predicting perinatal outcomes with an obstructive sleep apnea screening tool	3
HPV self-sampling and follow-up over two rounds of cervical screening in Australia – the iPap trial	3
Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, Australia	3
Practice, clinician, and patient factors associated with the adoption of lung cancer screening	3
The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area	3
Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India	3
Breast cancer mortality after eight years of an improved screening program using digital breast tomosynthesis	3
Breast cancer overdiagnosis in stop-screen trials: More uncertainty than previously reported	3
Evaluation of the Call for a Kit intervention to increase bowel cancer screening uptake in Lancashire, England	2
Morbidity and mortality following major large bowel resection for colorectal cancer detected by a population-based screening program	2
Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study	2
Sociodemographic changes in the population frequency of colonoscopy following the implementation of organised bowel cancer screening: An analysis of data from Swedish registers, 2006–2015	2
Hybrid capture 2 and cobas® 4800: Comparison of performance of two clinically validated tests for human papillomavirus primary screening of cervical cancer	2
Classifying interval cancers as false negatives or newly occurring in fecal immunochemical testing	2
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review	2

NHS announces a pilot of a blood test for early detection of many cancers	2
Evaluation of human papillomavirus self-collection offered by community health workers at home visits among under-screened women in Brazil	2
Interval cancer audit and disclosure in cervical screening programmes: An international survey	2
Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue	2
The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer	2
Availability of data for cost-effectiveness comparison of child vision and hearing screening programmes	2
Comparison of cytology and human papillomavirus-based primary testing in cervical screening programs in the Nordic countries	2
Factors associated with test failure in pregnant women undergoing cell-free DNA-based testing for fetal trisomy	2
Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study	2
The impact of cumulative colorectal cancer screening delays: A simulation study	2
Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: A systematic review	2
Overcoming barriers to lung cancer screening using a systemwide approach with additional focus on the non-screened	1
Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme	1
Why are most colorectal cancers diagnosed outside of screening? A retrospective analysis of data from the English bowel screening programme	1
Antenatal screening for Down’s syndrome: Revised nuchal translucency upper truncation limit due to improved precision of measurement	1
Time of day and mammographic reader performance in a population-based breast cancer screening programme	1
Efficacy and effectiveness	1
Colonoscopy may be weak link in organised colorectal cancer screening programme with faecal immunochemical test	1
Timely adherence to follow-up after high-risk lung cancer screenings	1
Participation and cancer detection after reminders versus ordinary invitations in BreastScreen Norway	1
Newborn screening for abnormal haemoglobins in Jamaica: Practical issues in an island programme	1
Populations at high risk of cervical cancer in Guangxi Province: Findings from two screening projects in a minority area of South China	1
Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy	1
Perceived susceptibility to developing cancer and screening for colorectal and prostate cancer: A longitudinal analysis of Alberta’s Tomorrow Project	1
Patterns of gynaecological check-up and their association with body mass index within the CONSTANCES cohort	1
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study	1
Impact of switching from digital mammography to tomosynthesis plus digital mammography on breast cancer screening in Alberta, Canada	1
Impact of changing from a guaiac faecal occult blood test to a faecal immunochemical test in a national screening programme: Results from a pilot study within the national bowel cancer screening progr	1
Response to Editorial: ‘Risk or chance’	1
Guidance on terminology	1
Risk or chance	1
Chloroquine and the potential adverse outcome in undiagnosed G6PD-deficient cases infected with COVID-19	1
Infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis and acute recurrent pancreatitis: what definition?	1
Age at breast cancer screening in women with intellectual disability	1